Tradestie Institutional Equity Comparison Engine
WGS vs NEOG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NEOG Overall Edge
NEOG Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Neogen Corp (NEOG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, WGS trades at 40.6x Forward P/E with -13.7% operating margin (+5.4% YoY revenue) versus NEOG at 36.3x Forward P/E and -0.8% operating margin (+6.5% YoY). In options structure, WGS sits in BREAKDOWN (21st %ile IV; Dealer Gamma Walls on Pro) against NEOG sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NEOG
WGS 40.6x vs NEOG 36.3x Fwd P/E
Growth & Margin Winner
NEOG
Op Margin -13.7% vs -0.8% ยท YoY +5.4% vs +6.5%
Momentum & Technical Winner
NEOG
1Y -60.9% vs +70.8% ยท 52W Pos 14% vs 62%
Options & Structure Winner
NEOG
BREAKDOWN (21st %ile IV) vs CONSOLIDATION (25th %ile IV)
WGS
NASDAQ
GeneDx Holdings Corp. Class A Common Stock
Services-Health Services
$51.02
-2.58% 1D
Market Cap
$1.6B
1M Return
-19.79%
1Y Return
-60.86%
Forward P/E
40.6x
Unified AI Score
49.5 / 100
HOLD
Tech 33.0
Fund 53.0
Flow 70.0
Mom 60.0
NEOG
NASDAQ
Neogen Corp
In Vitro & In Vivo Diagnostic Substances
$10.88
-3.12% 1D
Market Cap
$2.5B
1M Return
-7.87%
1Y Return
+70.8%
Forward P/E
36.3x
Unified AI Score
43.0 / 100
HOLD
Tech 23.0
Fund 46.0
Flow 61.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
WGS -60.86%
NEOG +70.8%
Spread: +131.66 pp (NEOG Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | WGS Revenue | NEOG Revenue | WGS Op. Margin | NEOG Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $200M | $410M | -15.5% | 16.4% | NEOG |
| FY2020 | $180M | $420M | -134.9% | 16.1% | NEOG |
| FY2021 | $210M | $470M | -210.3% | 15.8% | NEOG |
| FY2022 | $230M | $530M | -284.5% | 11.1% | NEOG |
| FY2023 | $200M | $820M | -89.2% | 4.6% | NEOG |
| FY2024 | $310M | $920M | -7.6% | 6.3% | NEOG |
| FY2025 | $430M | $890M | -3.1% | -118.6% | WGS |
| FY2026 | N/A | $870M | N/A | -2.5% | NEOG |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | WGS | NEOG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.6B | $2.5B | Larger Scale | NEOG |
| Trailing P/E Ratio Valuation | 38.8x | 16.0x | Lower Multiple | NEOG |
| Forward P/E Ratio Valuation | 40.6x | 36.3x | Lower Multiple | NEOG |
| Revenue Growth (YoY) Growth | +5.4% | +6.5% | Higher Growth | NEOG |
| Operating Margin (TTM) Profitability | -13.7% | -0.8% | Higher Margin | NEOG |
| Net Profit Margin Profitability | -24.1% | -6.3% | Higher Margin | NEOG |
| Return on Equity (ROE) Capital Efficiency | -41.4% | -2.7% | Higher ROE | NEOG |
| 52-Week Range Position Momentum | 14% ($32โ$171) | 62% ($5โ$14) | Stronger Trend | NEOG |
| Beta / 30D Volatility Risk Regime | 1.74ฮฒ ยท 111% Vol | 1.41ฮฒ ยท 40% Vol | Lower Realized Risk | NEOG |
| Unified Institutional Score Composite Signal | 49.5 / 100 (HOLD) | 43.0 / 100 (HOLD) | Higher Composite | WGS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full WGS vs NEOG Buy Guide
WGS
BREAKDOWN
96d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
21st %ile
IV Regime
Compressed (<25th %ile)
NEOG
CONSOLIDATION
39d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
25th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither WGS nor NEOG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.